Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tamamogullari N, Silig Y, Icagasioglu S, Atalay A
Somatostatin inhibits GH release
Ozempic is approved to help manage type 2 diabetes and reduce cardiovascular risk, while Wegovy is approved to assist with weight loss and for chronic weight management (in conjunction with a reduced-calorie diet and increased physical activity) in people with obesity or who are overweight with at least one weight-related condition
After reconstitution with a sterile diluent, store at 2 to 8 C (36 to 46 F) and use promptly within laboratory protocols
SOURCE Empower Pharmacy
The International Foundation of Employee Benefit Plans has been tracking GLP-1 coverage in Canada since February 2024
US$ 20.59
US$ 25.22
US$ 27.70
